Merz Pharma To Acquire BioForm Medical
BioForm Medical Inc. (Nasdaq: BFRM) will be acquired by privately held Merz Pharma Group for approximately $253 million sending the stock price soaring $2.05 to $5.45.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.